
Xiaoting Hu
Examiner (ID: 15314, Phone: (571)272-9222 , Office: P/3748 )
| Most Active Art Unit | 3746 |
| Art Unit(s) | 3748, 3746, 3762 |
| Total Applications | 618 |
| Issued Applications | 413 |
| Pending Applications | 41 |
| Abandoned Applications | 188 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6931119
[patent_doc_number] => 20050282154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/957880
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6337
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957880 | Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus | Oct 4, 2004 | Abandoned |
Array
(
[id] => 82682
[patent_doc_number] => 07740858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'SARS-CoV-specific B-cell epitope and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 10/945648
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4912
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/740/07740858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945648 | SARS-CoV-specific B-cell epitope and applications thereof | Sep 20, 2004 | Issued |
Array
(
[id] => 6939735
[patent_doc_number] => 20050113298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Receptor binding peptides derived from the SARS S protein'
[patent_app_type] => utility
[patent_app_number] => 10/939113
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7206
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113298.pdf
[firstpage_image] =>[orig_patent_app_number] => 10939113
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/939113 | Receptor binding peptides derived from the SARS S protein | Sep 12, 2004 | Abandoned |
Array
(
[id] => 43221
[patent_doc_number] => 07776546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Method and device for detecting feline immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/938097
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9910
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938097
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938097 | Method and device for detecting feline immunodeficiency virus | Sep 9, 2004 | Issued |
Array
(
[id] => 7127248
[patent_doc_number] => 20050058992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Method and device for detecting feline immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/938056
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9921
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058992.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938056 | Method and device for detecting feline immunodeficiency virus | Sep 9, 2004 | Issued |
Array
(
[id] => 6944332
[patent_doc_number] => 20050196381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Lentivirus vector-based approaches for generating an immune response to HIV in humans'
[patent_app_type] => utility
[patent_app_number] => 10/937026
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12844
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937026 | Lentivirus vector-based approaches for generating an immune response to HIV in humans | Sep 8, 2004 | Abandoned |
Array
(
[id] => 7033537
[patent_doc_number] => 20050032046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/936037
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7094
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936037 | Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus | Sep 7, 2004 | Abandoned |
Array
(
[id] => 6938992
[patent_doc_number] => 20050112555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof'
[patent_app_type] => utility
[patent_app_number] => 10/934090
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 48446
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934090 | Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof | Sep 2, 2004 | Abandoned |
Array
(
[id] => 252376
[patent_doc_number] => 07579008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Immunization with an attenuated human rotavirus'
[patent_app_type] => utility
[patent_app_number] => 10/929802
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 12766
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10929802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/929802 | Immunization with an attenuated human rotavirus | Aug 29, 2004 | Issued |
Array
(
[id] => 390322
[patent_doc_number] => 07300918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Method of producing vaccines from protein signal oligopeptides'
[patent_app_type] => utility
[patent_app_number] => 10/930300
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 7852
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10930300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/930300 | Method of producing vaccines from protein signal oligopeptides | Aug 29, 2004 | Issued |
Array
(
[id] => 6944362
[patent_doc_number] => 20050196411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Immunogenic HIV compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 10/928642
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13317
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928642 | Immunogenic HIV compositions and related methods | Aug 26, 2004 | Abandoned |
Array
(
[id] => 5894801
[patent_doc_number] => 20060003340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Multi-allelic molecular detection of SARS-associated coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/917421
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 83
[patent_no_of_words] => 8303
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917421 | Multi-allelic molecular detection of SARS-associated coronavirus | Aug 12, 2004 | Abandoned |
Array
(
[id] => 121110
[patent_doc_number] => 07709188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Multi-allelic detection of SARS-associated coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/569070
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 20
[patent_no_of_words] => 8669
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 337
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569070 | Multi-allelic detection of SARS-associated coronavirus | Aug 12, 2004 | Issued |
Array
(
[id] => 7060989
[patent_doc_number] => 20050003350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Novel methods for HIV sequencing and genotyping'
[patent_app_type] => utility
[patent_app_number] => 10/915998
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10915998
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/915998 | Novel methods for HIV sequencing and genotyping | Aug 9, 2004 | Abandoned |
Array
(
[id] => 7252438
[patent_doc_number] => 20050074854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Glycosylated specificity exchangers'
[patent_app_type] => utility
[patent_app_number] => 10/913754
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10913754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/913754 | Glycosylated specificity exchangers | Aug 5, 2004 | Issued |
Array
(
[id] => 7326797
[patent_doc_number] => 20040253210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Adenovirus type7 vectors'
[patent_app_type] => new
[patent_app_number] => 10/487974
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8883
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487974 | Adenovirus type7 vectors | Aug 4, 2004 | Abandoned |
Array
(
[id] => 5028914
[patent_doc_number] => 20070270361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/565314
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 18094
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270361.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565314 | Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof | Aug 3, 2004 | Abandoned |
Array
(
[id] => 6918057
[patent_doc_number] => 20050095618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS)'
[patent_app_type] => utility
[patent_app_number] => 10/901744
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23297
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095618.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901744 | Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS) | Jul 27, 2004 | Issued |
Array
(
[id] => 7254862
[patent_doc_number] => 20050075292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Compositions and methods for treating HIV infections'
[patent_app_type] => utility
[patent_app_number] => 10/891825
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26348
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075292.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891825 | Compositions of beta-defensin inducing agents | Jul 13, 2004 | Issued |
Array
(
[id] => 6938990
[patent_doc_number] => 20050112553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Mammalian genes involved in viral infection and tumor suppression'
[patent_app_type] => utility
[patent_app_number] => 10/877807
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16196
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877807 | Mammalian genes involved in viral infection and tumor suppression | Jun 24, 2004 | Abandoned |